Salicylate hypoglycemic action in alloxan-diabetic rats and structural relationships.
D000818:Animals; D001555:Benzene Derivatives / Q000627:therapeutic use; D001786:Blood Glucose; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D005260:Female; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D008297:Male; D008403:Mass Screening; D009539:Nicotinic Acids / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D011726:Pyridinium Compounds / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D051381:Rats; D012459:Salicylates / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use
D001555:Benzene Derivatives; D001786:Blood Glucose; D006571:Heterocyclic Compounds; D009539:Nicotinic Acids; D011719:Pyrazines; D011726:Pyridinium Compounds; D011743:Pyrimidines; D011758:Pyrroles; D012459:Salicylates; D013876:Thiophenes